Association Between Youth Smoking, Electronic Cigarette Use, and COVID-19
- PMID: 32798097
- PMCID: PMC7417895
- DOI: 10.1016/j.jadohealth.2020.07.002
Association Between Youth Smoking, Electronic Cigarette Use, and COVID-19
Abstract
Purpose: This study aimed to assess whether youth cigarette and electronic cigarette (e-cigarette) use are associated with coronavirus disease 2019 (COVID-19) symptoms, testing, and diagnosis.
Methods: An online national survey of adolescents and young adults (n = 4,351) aged 13-24 years was conducted in May 2020. Multivariable logistic regression assessed relationships among COVID-19-related symptoms, testing, and diagnosis and cigarettes only, e-cigarettes only and dual use, sociodemographic factors, obesity, and complying with shelter-in-place.
Results: COVID-19 diagnosis was five times more likely among ever-users of e-cigarettes only (95% confidence interval [CI]: 1.82-13.96), seven times more likely among ever-dual-users (95% CI: 1.98-24.55), and 6.8 times more likely among past 30-day dual-users (95% CI: 2.40-19.55). Testing was nine times more likely among past 30-day dual-users (95% CI: 5.43-15.47) and 2.6 times more likely among past 30-day e-cigarette only users (95% CI: 1.33-4.87). Symptoms were 4.7 times more likely among past 30-day dual-users (95% CI: 3.07-7.16).
Conclusions: COVID-19 is associated with youth use of e-cigarettes only and dual use of e-cigarettes and cigarettes, suggesting the need for screening and education.
Keywords: COVID; Communicable disease; Coronavirus; Electronic cigarette; Infectious disease; Lung; Pandemic; Smoking; Tobacco.
Copyright © 2020 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved.
Comment in
-
E-Cigarette Use and COVID-19: Questioning Data Reliability.J Adolesc Health. 2021 Jan;68(1):213. doi: 10.1016/j.jadohealth.2020.09.012. J Adolesc Health. 2021. PMID: 33349352 Free PMC article. No abstract available.
-
In Response to "Association Between Youth Smoking, Electronic Cigarette Use, and COVID-19".J Adolesc Health. 2021 Jan;68(1):214. doi: 10.1016/j.jadohealth.2020.10.002. J Adolesc Health. 2021. PMID: 33349353 No abstract available.
-
Gaiha et al. Disregarded Conventional Publishing Standards.J Adolesc Health. 2021 Jan;68(1):215. doi: 10.1016/j.jadohealth.2020.09.013. J Adolesc Health. 2021. PMID: 33349354 No abstract available.
-
Gaiha et al. Response.J Adolesc Health. 2021 Jan;68(1):215-216. doi: 10.1016/j.jadohealth.2020.09.014. J Adolesc Health. 2021. PMID: 33349355 No abstract available.
-
The Authors Respond.J Adolesc Health. 2021 Jan;68(1):216-221. doi: 10.1016/j.jadohealth.2020.10.017. J Adolesc Health. 2021. PMID: 33349356 No abstract available.
-
The Editors Respond.J Adolesc Health. 2021 Jan;68(1):221-222. doi: 10.1016/j.jadohealth.2020.09.016. J Adolesc Health. 2021. PMID: 33349357 No abstract available.
References
-
- U.S. Centers for Disease Control and Prevention Cases in the US. https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/cases-in-us.html Available at:
-
- National Institute of Drug Abuse COVID-19: Potential implications for individuals with substance use disorders. https://www.drugabuse.gov/about-nida/noras-blog/2020/04/covid-19-potenti... Available at:
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
